Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U S Bergerheim

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Oncogene|October 1, 1994
Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridizationH Matsuyama, Y Pan, L Skoog, et al.
Genes, Chromosomes & Cancer|January 3, 2001
5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell linesY Pan, W O Lui, N Nupponen, et al.
The Prostate|July 3, 1998
Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancerY Pan, H Matsuyama, N Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancerH Matsuyama, Y Pan, K Oba, et al.
Cytogenetics and Cell Genetics|March 7, 2000
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotypingY Pan, S Kytölä, F Farnebo, et al.
The Journal of Urology|March 1, 1995
Hereditary papillary renal cell carcinoma: clinical studies in 10 familiesB Zbar, G Glenn, I Lubensky, et al.
Oncogene|March 4, 1998
Identification of two distinct deleted regions on chromosome 13 in prostate cancerC Li, C Larsson, A Futreal, et al.
Cancer Genetics and Cytogenetics|February 1, 1996
Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell linesU S Bergerheim, M Söderhäll, E Zabarovsky, et al.
Genes, Chromosomes & Cancer|August 19, 1999
Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancerC Li, G Berx, C Larsson, et al.
Experimental Hematology|March 1, 1992
KBM-3, an in vitro model of human acute myelomonocytic leukemiaB S Andersson, U S Bergerheim, V P Collins, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Oncogene|October 1, 1994
Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridizationH Matsuyama, Y Pan, L Skoog, et al.
Genes, Chromosomes & Cancer|January 3, 2001
5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell linesY Pan, W O Lui, N Nupponen, et al.
The Prostate|July 3, 1998
Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancerY Pan, H Matsuyama, N Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancerH Matsuyama, Y Pan, K Oba, et al.
Cytogenetics and Cell Genetics|March 7, 2000
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotypingY Pan, S Kytölä, F Farnebo, et al.
The Journal of Urology|March 1, 1995
Hereditary papillary renal cell carcinoma: clinical studies in 10 familiesB Zbar, G Glenn, I Lubensky, et al.
Oncogene|March 4, 1998
Identification of two distinct deleted regions on chromosome 13 in prostate cancerC Li, C Larsson, A Futreal, et al.
Cancer Genetics and Cytogenetics|February 1, 1996
Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell linesU S Bergerheim, M Söderhäll, E Zabarovsky, et al.
Genes, Chromosomes & Cancer|August 19, 1999
Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancerC Li, G Berx, C Larsson, et al.
Experimental Hematology|March 1, 1992
KBM-3, an in vitro model of human acute myelomonocytic leukemiaB S Andersson, U S Bergerheim, V P Collins, et al.
Pageof 3